Prothena Biosciences (PRTA) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Prothena Corporation (PRTA) amiloidoz terapiyalarining yetakchi ishlab chiquvchisi bo'lib, Parkinson kasalligi bilan bog'liq patologik oqsillarni yo'q qilish uchun antitanachalar yaratmoqda. GURU.Markets platformasida mavjud narx harakati vektori 0.01 darajasida qayd etilgan. Biznes barqarorligi AQSh va Irlandiyadagi markazlar tomonidan qo'llab-quvvatlanadi, ular korporativ gigantlar bilan hamkorlikda Altsgeymer kasalligi davolash vositalarini ishlab chiqishmoqda. Biroq, aksiyalar narxining klinik sinovlar natijalariga bog'liqligi sababli yuqori tebranishlar saqlanib qolmoqda.
&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_PRTA_-_Prothena-Corporation_-_Long-Term-Debt-to-Equity-Ratio "PRTA - Prothena Corporation Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 29.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Prothena Corporation kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Prothena Corporation|PRTA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Prothena Corp|PRTA - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Prothena Corporation plc|PRTA - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Prothena
Kompaniyaning har tomonlama tahlili:Prothena Corporation - PRTA
Moliyaviy barqarorlik Prothena Corporation (PRTA) uchun juda muhimdir, bu kompaniya qimmatga tushadigan R&D va RSU orqali olimlarni saqlab qolishga investitsiya kiritayotgan biotexnologiya kompaniyasi hisoblanadi. Uzoq muddatli qarzning kapitalga nisbati kapital tuzilmasi ichida muddati bir yildan oshadigan kreditlarning ulushini aks ettiradi, bunda past qiymatlar konservativ moliyalashtirish yondashuvini tasdiqlaydi, ko'tarilish esa dori vositalarini ishlab chiqishni tezlashtirish uchun leverajdan foydalanilganini ko'rsatadi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|harmonybiosciences.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|AMLX (Amylyx Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Praxis Corp (PRAX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|AVXL: Uzoq muddatli qarzning o'z kapitaliga nisbati|ceribell.com - Uzoq muddatli kreditlarning kapitalga nisbati|ALEC: Uzoq muddatli qarzning kapitalga nisbati|Annexon Biosciences - Uzoq muddatli qarzning kapitalga koeffitsiyenti|OMER (Omeros Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Neurogene Therapeutics NGNE|Uzoq muddatli qarzning o'z kapitaliga nisbati AC Immune (ACIU)|voyagertherapeutics.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati NMRA (Neumora Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Scilex Holding SCLX|TVGN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACOG (Alpha Cognition)|CGTX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati inhibikase.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Cassava Sciences|Uzoq muddatli majburiyatlarning kapitalga nisbati Assertio Therapeutics ASRT|Uzoq muddatli qarzning o'z kapitaliga nisbati Coya Therapeutics, Inc. (COYA)|VTGN (vistagen.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Ovid Therapeutics OVID|ABOS (acumenpharm.com) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alterity Therapeutics|clene.com (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PepGen - Uzoq muddatli qarzning kapitalga koeffitsiyenti|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati relmada.com|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio)|Uzoq muddatli kreditlarning kapitalga nisbati GRCE|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|Uzoq muddatli qarzdorlikning kapitalga nisbati ANEW Medical (KLTO)|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati revivapharma.com|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NRXS|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Passage Bio Corp - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|NERV (minervaneurosciences.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ADXN (Addex Therapeutics Ltd.)|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|CYCN - Uzoq muddatli qarzning kapitalga nisbati|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi KTTA|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Avenue Therapeutics Inc. ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati BCLI (Brainstorm Cell Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Cara Therapeutics Inc (CARA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Uzoq muddatli qarzning kapitalga koeffitsiyenti ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati NKGN (NKGen Biotech Corp)|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|SAGE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati WENA (Anew Medical Inc.)|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati